PH24528A - Steroid lotion - Google Patents

Steroid lotion

Info

Publication number
PH24528A
PH24528A PH36943A PH36943A PH24528A PH 24528 A PH24528 A PH 24528A PH 36943 A PH36943 A PH 36943A PH 36943 A PH36943 A PH 36943A PH 24528 A PH24528 A PH 24528A
Authority
PH
Philippines
Prior art keywords
steroid
lotion
steroid lotion
corticosteroids
hydro
Prior art date
Application number
PH36943A
Other languages
English (en)
Inventor
Joel A Sequeira
Farah J Munayyer
Rebecca Galeos
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21982389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH24528(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of PH24528A publication Critical patent/PH24528A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH36943A 1987-05-21 1988-05-18 Steroid lotion PH24528A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/053,172 US4775529A (en) 1987-05-21 1987-05-21 Steroid lotion

Publications (1)

Publication Number Publication Date
PH24528A true PH24528A (en) 1990-07-18

Family

ID=21982389

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36943A PH24528A (en) 1987-05-21 1988-05-18 Steroid lotion

Country Status (22)

Country Link
US (1) US4775529A (de)
EP (2) EP0292893B2 (de)
JP (1) JP2572124B2 (de)
KR (2) KR930010584B1 (de)
AT (1) ATE77745T1 (de)
AU (1) AU616188B2 (de)
CA (1) CA1307207C (de)
DE (1) DE3872521T3 (de)
DK (1) DK581989A (de)
ES (1) ES2032898T5 (de)
FI (1) FI95350C (de)
GR (2) GR3005762T3 (de)
HK (1) HK60595A (de)
IE (1) IE60546B1 (de)
IL (1) IL86440A (de)
MX (1) MX9203285A (de)
MY (1) MY103280A (de)
NO (1) NO175762C (de)
NZ (1) NZ224707A (de)
PH (1) PH24528A (de)
WO (1) WO1988009174A1 (de)
ZA (1) ZA883566B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942158A (en) * 1988-10-13 1990-07-17 Eastman Kodak Transdermal steroid penetrant compositions and methods utilizing isopropanol and isobutanol
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
NZ278198A (en) * 1993-12-21 1997-12-19 Schering Corp Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis
DE4344697A1 (de) * 1993-12-27 1995-06-29 Beiersdorf Ag Corticosteroide enthaltende W/O-Lotion
US6623744B2 (en) 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
EP1374847A1 (de) * 1995-06-22 2004-01-02 Minnesota Mining And Manufacturing Company Stabile Alkoholisch-Wassrige Zusammensetzung
US7566460B2 (en) * 1995-06-22 2009-07-28 3M Innovative Properties Company Stable hydroalcoholic compositions
RU2106860C1 (ru) * 1996-01-30 1998-03-20 Акционерное общество открытого типа "Нижегородский химико-фармацевтический завод" Состав и способ получения мази противовоспалительного и противозудного действия
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6582711B1 (en) 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
EP0969847A1 (de) * 1997-02-20 2000-01-12 Allergan Sales, Inc. Tazarotene und carticosteroid enthaltende zusammensetzungen zur behandlung von psoriasis
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
FI974610A0 (fi) * 1997-12-23 1997-12-23 Leiras Oy Farmaceutiskt preparat i gelform
US8329758B2 (en) * 2002-02-05 2012-12-11 Gojo Industries, Inc. Skin sanitizing antimicrobial alcoholic compositions
KR20040034795A (ko) * 2002-10-17 2004-04-29 박래옥 스테로이드 제제 및 태반 추출물을 함유한 염증성 피부병치료용 경피제
EP1624861A2 (de) 2003-05-23 2006-02-15 Taro Pharmaceuticals Industries Ltd. Neue topische steroid-cremeformulierungen
EP1888026A4 (de) 2005-05-27 2012-07-04 Taro Pharmaceuticals North America Inc Stabile flüssigformulierung mit desoximetason und isopropylmyristat mit reduzierter oxidierter verunreinigung während langzeitiger lagerung
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007070423A2 (en) * 2005-12-09 2007-06-21 Nycomed Us Inc. Topical glucocorticosteroid formulations
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
EP2394653A1 (de) 2010-05-26 2011-12-14 Almirall, S.A. Topische pharmazeutische Zusammensetzungen enthaltend Mometasonfuroat

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2890152A (en) * 1956-11-29 1959-06-09 Schering Corp Topical anti-inflammatory compositions
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US3711606A (en) * 1970-09-02 1973-01-16 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active steroidal agents with dmso
DK135267A (de) * 1971-02-25
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
US4013792A (en) * 1974-04-11 1977-03-22 Warner-Lambert Company Process for the production of base for topical steroids
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
JPS6013711A (ja) * 1983-06-21 1985-01-24 ザ、プロクタ−、エンド、ギヤンブル、カンパニ− コルチコステロイドを含有する浸透局所製薬組成物
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
KR930010584B1 (ko) 1993-10-30
NO175762C (no) 1994-12-07
NO175762B (no) 1994-08-29
KR890701109A (ko) 1989-12-19
CA1307207C (en) 1992-09-08
NO890271D0 (no) 1989-01-20
FI895482A0 (fi) 1989-11-17
IL86440A0 (en) 1988-11-15
GR3005762T3 (en) 1993-06-07
ES2032898T5 (es) 1996-03-01
EP0362270B2 (de) 1999-11-24
DE3872521T3 (de) 2000-06-21
EP0292893A1 (de) 1988-11-30
DK581989D0 (da) 1989-11-20
IE60546B1 (en) 1994-07-27
DE3872521D1 (de) 1992-08-06
GR3018818T3 (en) 1996-04-30
EP0362270B1 (de) 1992-07-01
FI95350C (fi) 1996-01-25
FI95350B (fi) 1995-10-13
EP0292893B2 (de) 1995-11-29
JP2572124B2 (ja) 1997-01-16
AU616188B2 (en) 1991-10-24
NZ224707A (en) 1990-09-26
NO890271L (no) 1989-01-20
MX9203285A (es) 1992-07-01
IL86440A (en) 1993-01-31
US4775529A (en) 1988-10-04
IE881517L (en) 1988-11-21
EP0362270A1 (de) 1990-04-11
JPH02501739A (ja) 1990-06-14
AU1941788A (en) 1988-12-21
WO1988009174A1 (en) 1988-12-01
ES2032898T3 (es) 1993-03-01
MY103280A (en) 1993-05-29
DK581989A (da) 1989-11-20
DE3872521T2 (de) 1992-12-10
ATE77745T1 (de) 1992-07-15
HK60595A (en) 1995-04-28
EP0292893B1 (de) 1992-07-01
ZA883566B (en) 1989-01-25

Similar Documents

Publication Publication Date Title
IE881517L (en) Steroid lotion
EP0242643A3 (en) Nasal administration of drugs
AU576724B2 (en) Transdermally delivering nitroglycerine
PH23440A (en) Anti-inflammatory cream composition
ZA874621B (en) Novel pharmaceutical compositions for topical application with systemic action
DE3378634D1 (en) Pharmaceutically active pteridine derivatives
PT76504A (en) Perfluorohydrocarbons as vehicles for administering drugs
EP0303435A3 (en) Bipolar transistors
IL74853A (en) Transdermally effective topical anti-allergic pharmaceutical compositions comprising azatadine
DE3766885D1 (en) Chlorpheniramine therapie.
IE810891L (en) Topical formulation
AU5609386A (en) Topical agents for inhibiting the melanin generation
GB1514113A (en) Therapeutic compositions containing dimercapto-diethyl ether derivatives
GB2165450B (en) Skin-patch for use in the topical administration of ointment
IE871714L (en) Pharmaceutical compositions for topical administration
GB8316087D0 (en) Topical pharmaceutical preparations
GB8710618D0 (en) Bipolar transistors
GB8902424D0 (en) Medicinal formulations
GB8811448D0 (en) Novel anti-inflammatory agents pharmaceutical compositions & methods for reducing inflammation